- Home
- TVRD vs TPCS Comparison
TVRD vs TPCS Comparison
Compare TVRD & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TVRD | TPCS |
|---|---|---|
| Founded | 2017 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.3M | 40.9M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | TVRD | TPCS |
|---|---|---|
| Price | $3.64 | $3.93 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $51.67 | N/A |
| AVG Volume (30 Days) | ★ 51.6K | 30.0K |
| Earning Date | 01-01-0001 | 05-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 64.20 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $34,031,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.72 |
| 52 Week Low | $3.50 | $2.08 |
| 52 Week High | $43.65 | $6.25 |
Technical Indicators
Market Signals| Indicator | TVRD | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 40.19 | 30.74 |
| Support Level | $3.51 | $3.67 |
| Resistance Level | $3.89 | $4.87 |
| Average True Range (ATR) | 0.29 | 0.26 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 23.40 | 22.82 |
Price Performance
Historical ComparisonAbout TVRD Tvardi Therapeutics Inc.
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About TPCS TechPrecision Corporation
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.